Christopher Vandeusen
Head of Medicinal Chemistry
Genetics
Chemical Computing Group
Spain
Biography
Dr. VanDeusen lead drug discovery teams for over 14 years in at Genzyme and Sanofi legacy companies. Most recently, he was a global project leader within the Tissue Protection and Repair unit within Genzyme. While at Sanofi, he was the head of the chemistry division within Tissue Protection and Repair specializing in Inflammation and Fibrosis research. Chris has contributed to multiple entities entering into clinical development, and is the inventor of an H-PGDS inhibitor currently in development for COPD. Dr. VanDeusen holds a BA in Chemistry from Wittenberg University and a PhD in Chemistry from Stanford University. He is also the President and co-Founder of Omdana Therapeutics, Inc.
Research Interest
Genetics
